Pro-Tect also plans to develop and commercialize once-daily opioid combinations as well as abuse-deterrent opioid combinations for moderate to severe pain. This patents acquisition includes a pain ...
PRO-TECT randomized 26 community oncology practices to the PROM intervention arm where concerning symptoms generated automated alerts to nurses. IVR and web patients were compared for social ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback